C9488 HCPCS Level II code: Injection, conivaptan hydrochloride, 1 mg
C9488 is the HCPCS code for “Injection, conivaptan hydrochloride, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9488Injection, conivaptan hydrochloride, 1 mg
Short description: Conivaptan hcl
HCPCS · United States
Medicare details
The indicators CMS publishes with C9488 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Added
- Apr 1, 2017
Where C9488 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9488Injection, conivaptan hydrochloride, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9488 mean?
C9488 is the HCPCS code for “Injection, conivaptan hydrochloride, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9488?
CMS lists C9488’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9488
All C codesC9482Injection, sotalol hydrochloride, 1 mgC9483Injection, atezolizumab, 10 mgC9484Injection, eteplirsen, 10 mgC9485Injection, olaratumab, 10 mgC9486Injection, granisetron extended release, 0.1 mgC9487Ustekinumab, for intravenous injection, 1 mgC9489Injection, nusinersen, 0.1 mgC9490Injection, bezlotoxumab, 10 mgC9491Injection, avelumab, 10 mgC9492Injection, durvalumab, 10 mgC9493Injection, edaravone, 1 mgC9494Injection, ocrelizumab, 1 mg